Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
44
pubmed:dateCreated
2003-10-31
pubmed:commentsCorrections
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Acrylates, http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin I, http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II, http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin Receptor Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme..., http://linkedlifedata.com/resource/pubmed/chemical/Anti-Arrhythmia Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Benzimidazoles, http://linkedlifedata.com/resource/pubmed/chemical/Benzoates, http://linkedlifedata.com/resource/pubmed/chemical/Biphenyl Compounds, http://linkedlifedata.com/resource/pubmed/chemical/EXP3174, http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles, http://linkedlifedata.com/resource/pubmed/chemical/Losartan, http://linkedlifedata.com/resource/pubmed/chemical/Placebos, http://linkedlifedata.com/resource/pubmed/chemical/Tetrazoles, http://linkedlifedata.com/resource/pubmed/chemical/Thiophenes, http://linkedlifedata.com/resource/pubmed/chemical/Valine, http://linkedlifedata.com/resource/pubmed/chemical/candesartan, http://linkedlifedata.com/resource/pubmed/chemical/eprosartan, http://linkedlifedata.com/resource/pubmed/chemical/irbesartan, http://linkedlifedata.com/resource/pubmed/chemical/olmesartan medoxomil, http://linkedlifedata.com/resource/pubmed/chemical/telmisartan, http://linkedlifedata.com/resource/pubmed/chemical/valsartan
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0012-0472
pubmed:author
pubmed:issnType
Print
pubmed:day
31
pubmed:volume
128
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2315-8
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:14593575-Acrylates, pubmed-meshheading:14593575-Angiotensin I, pubmed-meshheading:14593575-Angiotensin II, pubmed-meshheading:14593575-Angiotensin Receptor Antagonists, pubmed-meshheading:14593575-Angiotensin-Converting Enzyme Inhibitors, pubmed-meshheading:14593575-Anti-Arrhythmia Agents, pubmed-meshheading:14593575-Antihypertensive Agents, pubmed-meshheading:14593575-Benzimidazoles, pubmed-meshheading:14593575-Benzoates, pubmed-meshheading:14593575-Biphenyl Compounds, pubmed-meshheading:14593575-Clinical Trials as Topic, pubmed-meshheading:14593575-Germany, pubmed-meshheading:14593575-Humans, pubmed-meshheading:14593575-Hypertension, pubmed-meshheading:14593575-Imidazoles, pubmed-meshheading:14593575-Losartan, pubmed-meshheading:14593575-Placebos, pubmed-meshheading:14593575-Tetrazoles, pubmed-meshheading:14593575-Therapeutic Equivalency, pubmed-meshheading:14593575-Thiophenes, pubmed-meshheading:14593575-Time Factors, pubmed-meshheading:14593575-Valine
pubmed:year
2003
pubmed:articleTitle
[Dosage equivalents of AT1-receptor antagonists available in Germany].
pubmed:affiliation
Institut für experimentelle und klinische Pharmakologie und Toxikologie, Universitätsklinikum Schleswig-Holstein, Campus Lübeck. dominiak@medinf.mu-luebeck.de
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't